NCT00731393View on ClinicalTrials.gov

Immuno & Reacto of TF Trivalent Influenza Split Vaccine 2003/04 or of Std Formulation Influsplit SSW®/Fluarix™ 2003/04

PHASE3CompletedINTERVENTIONAL
Enrollment

157

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions
Influenza
Interventions
BIOLOGICAL

Thiomersal free trivalent influenza split vaccine 2003/2004

2 doses, intramuscular injection

BIOLOGICAL

GlaxoSmithKline Biologicals' Influsplit SSW®/Fluarix™ 2003/2004

2 doses, intramuscular injection

Trial Locations (13)

10315

GSK Investigational Site, Berlin

12627

GSK Investigational Site, Berlin

13355

GSK Investigational Site, Berlin

18106

GSK Investigational Site, Rostock

18246

GSK Investigational Site, Bützow

23795

GSK Investigational Site, Bad Segeberg

24937

GSK Investigational Site, Flensburg

25813

GSK Investigational Site, Husum

01877

GSK Investigational Site, Bischofswerda

01640

GSK Investigational Site, Coswig

01169

GSK Investigational Site, Dresden

01307

GSK Investigational Site, Dresden

04209

GSK Investigational Site, Leipzig

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY